{"nctId":"NCT01786902","briefTitle":"Efficacy and Safety of DA-3002 in Children With Idiopathic Short Stature","startDateStruct":{"date":"2012-02"},"conditions":["Idiopathic Short Stature"],"count":70,"armGroups":[{"label":"DA-3002 Treatment group","type":"EXPERIMENTAL","interventionNames":["Drug: DA-3002"]},{"label":"Non-treatment control group","type":"NO_INTERVENTION","interventionNames":[]}],"interventions":[{"name":"DA-3002","otherNames":["Recombinant Human Growth Hormone"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Chronological Age â‰¥ 4\n* Bone Age \\<11 (for girls) and \\<13 (for boys)\n* Height \\<3rd percentile for age\n* normal thyroid function\n\nExclusion Criteria:\n\n* endocrine and/or metabolic disorders\n* growth failure caused by other disorders\n* previous use of drugs that could interfere with Growth Hormone treatment","healthyVolunteers":false,"sex":"ALL","minimumAge":"4 Years","maximumAge":"13 Years","stdAges":["CHILD"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Annualized Height Velocity(cm/Year) After 26 Weeks","description":"Height Velocity calculated with height measured at Baseline and after 26 weeks was converted to annual growth rate.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10.68","spread":"1.95"},{"groupId":"OG001","value":"5.72","spread":"1.72"}]}]}]},{"type":"SECONDARY","title":"Changes in Height Standard Deviation Score After 26 Weeks","description":"The Height Standard Deviation Score was calculated as height minus reference mean height divided by the standard deviation of the reference mean height, both given by a reference growth table for the corresponding chronological age at the height measurement. Greater Height Standard Deviation Score indicates greater height.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.63","spread":"0.16"},{"groupId":"OG001","value":"0.06","spread":"0.15"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Changes in Anti-growth Hormone Antibody","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.30","spread":"0.35"},{"groupId":"OG001","value":"0.21","spread":"0.54"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":1,"n":36},"commonTop":["Upper respiratory tract infection","Pyrexia","Hypersensitivity","Enteritis","Nausea"]}}}